Tonix Pharma's market cap is currently $54.06M. The company's EPS TTM is $-20.557; its P/E ratio is ―; Tonix Pharma is scheduled to report earnings on March 17, 2025, and the estimated EPS forecast is $-18.50. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 7.77M	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ 3.03M	$ -112.09M	$ -92.31M	$ -50.51M	$ -28.83M
Operating Income	$ -118.38M	$ -112.09M	$ -92.31M	$ -50.51M	$ -28.83M
EBITDA	$ -114.09M	$ -110.84M	$ -92.26M	$ -50.48M	$ -28.80M
Net Income	$ -116.66M	$ -116.88M	$ -92.29M	$ -52.17M	$ -31.09M
Balance Sheet
Cash & Short-Term Investments	$ 24.95M	$ 120.23M	$ 178.66M	$ 77.07M	$ 11.25M
Total Assets	$ 154.46M	$ 225.69M	$ 240.90M	$ 98.18M	$ 14.56M
Total Debt	$ 9.81M	$ 760.00K	$ 956.00K	$ 1.31M	$ 358.00K
Net Debt	$ -15.13M	$ -119.47M	$ -177.70M	$ -75.76M	$ -10.89M
Total Liabilities	$ 48.93M	$ 18.51M	$ 22.18M	$ 10.54M	$ 5.14M
Stockholders' Equity	$ 105.53M	$ 207.18M	$ 218.72M	$ 87.65M	$ 9.42M
Cash Flow
Free Cash Flow	$ -109.90M	$ -146.20M	$ -110.86M	$ -57.13M	$ -26.70M
Operating Cash Flow	$ -102.00M	$ -98.05M	$ -75.56M	$ -48.57M	$ -26.68M
Investing Cash Flow	$ -29.07M	$ -48.15M	$ -35.31M	$ -8.56M	$ -17.00K
Financing Cash Flow	$ 36.52M	$ 87.84M	$ 212.49M	$ 123.11M	$ 12.92M

Currency in USD

Tonix Pharma Earnings and Revenue History

Income Statement >

Tonix Pharma Debt to Assets

Balance Sheet >

Tonix Pharma Cash Flow

Cash Flow >

Tonix Pharma Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing